ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MR, MYOK, CBLI, SBPH, PTI, PRCP

<br /> ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MR, MYOK, CBLI, SBPH, PTI, PRCP<br />

PR Newswire


NEW YORK

,

Oct. 31, 2020

/PRNewswire/ — Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:



Montage Resources Corporation (NYSE: MR)




concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Southwestern Energy Company.


If you are a Montage shareholder, c




lick




on this link to learn more about your rights and options:


Montage Resources Corporation



.



MyoKardia, Inc. (NASDAQ: MYOK)


concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Bristol-Myers Squibb Company for

$225.50

per share in cash.


If you are a MyoKardia shareholder, c




lick




on this link to learn more about your rights and options:


MyoKardia, Inc.



.



Cleveland BioLabs, Inc. (NASDAQ: CBLI)


concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company.


If you are a Cleveland BioLabs shareholder, click




on this link to learn more about your rights and options:


Cleveland BioLabs, Inc.



.



Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)


concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its proposed merger with F-star Therapeutics, Limited.


If you are a

Spring Bank

shareholder, c




lick




on this link to learn more about your rights and options:


Spring Bank Pharmaceuticals, Inc.



.


Proteostasis Therapeutics, Inc. (NASDAQ: PTI)

concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Yumanity Therapeutics.


If you are a Proteostasis shareholder, c




lick




on this link to learn more about your rights and options:


Proteostasis Therapeutics, Inc.



.



Perceptron, Inc. (NASDAQ: PRCP)


concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Atlas Copco for

$7.00

per share.


If you are a Perceptron shareholder, click on this link to learn more about your rights and options:


Perceptron, Inc.



.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm


free of charge


to discuss their legal rights and options. Please call

Daniel Sadeh

or

Zachary Halper

at (212) 763-0060 or email

[email protected]

or

[email protected]

.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP


Daniel Sadeh, Esq.



Zachary Halper, Esq.


(212) 763-0060


[email protected]



[email protected]


Home


Cision
View original content to download multimedia:

http://www.prnewswire.com/news-releases/alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-investigations-investors-are-encouraged-to-contact-the-firm–mr-myok-cbli-sbph-pti-prcp-301164330.html

SOURCE Halper Sadeh LLP

If You Liked This Article Click To Share

Biotech